Your browser doesn't support javascript.
loading
αCT1 peptide sensitizes glioma cells to temozolomide in a glioblastoma organoid platform.
Che, Jingru; DePalma, Thomas J; Sivakumar, Hemamylammal; Mezache, Louisa S; Tallman, Miranda M; Venere, Monica; Swindle-Reilly, Katelyn; Veeraraghavan, Rengasayee; Skardal, Aleksander.
Afiliação
  • Che J; Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio, USA.
  • DePalma TJ; Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio, USA.
  • Sivakumar H; The Ohio State University and Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
  • Mezache LS; Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio, USA.
  • Tallman MM; Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio, USA.
  • Venere M; Biomedical Sciences Graduate Program, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Swindle-Reilly K; Dorothy M. Davis Hearth and Lung Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Veeraraghavan R; Department of Radiation Oncology, James Cancer Hospital and Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Skardal A; The Ohio State University and Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
Biotechnol Bioeng ; 120(4): 1108-1119, 2023 04.
Article em En | MEDLINE | ID: mdl-36544242

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma / Glioma Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma / Glioma Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article